Springer eBooks, Год журнала: 2023, Номер unknown, С. 1 - 12
Опубликована: Янв. 1, 2023
Springer eBooks, Год журнала: 2023, Номер unknown, С. 1 - 12
Опубликована: Янв. 1, 2023
Food and Chemical Toxicology, Год журнала: 2025, Номер 197, С. 115314 - 115314
Опубликована: Фев. 7, 2025
Язык: Английский
Процитировано
1AJP Renal Physiology, Год журнала: 2024, Номер 326(6), С. F894 - F916
Опубликована: Апрель 18, 2024
Mild cognitive impairment (MCI) is common in people with chronic kidney disease (CKD), and its prevalence increases progressive loss of function. MCI characterized by a decline performance greater than expected for an individual age education level but minimal instrumental activities daily living. Deterioration can affect one or several domains (attention, memory, executive functions, language, perceptual motor social cognition). Given the increasing disease, more CKD will also develop causing enormous burden these individuals, their relatives, society. However, underlying pathomechanisms are poorly understood, current therapies mostly aim at supporting patients lives. This illustrates urgent need to elucidate pathogenesis potential therapeutic targets test novel appropriate preclinical models. Here, we outline necessary criteria experimental modeling disorders CKD. We discuss use mice, rats, zebrafish as model systems present valuable techniques through which function be assessed this setting. Our objective enable researchers overcome hurdles accelerate research aimed improving therapy MCI.
Язык: Английский
Процитировано
4Journal of Nephrology, Год журнала: 2024, Номер 37(5), С. 1391 - 1395
Опубликована: Апрель 16, 2024
Язык: Английский
Процитировано
4Springer eBooks, Год журнала: 2025, Номер unknown, С. 553 - 564
Опубликована: Янв. 1, 2025
Процитировано
0Опубликована: Май 21, 2024
Cerebral ischemic stroke poses a significant global cause of death, with ischemia-reperfusion injury contributing to neuronal cell death and tissue damage. However, therapeutic approaches meaningful treatment effects for patients in actual clinical practice are lacking. This study investigated the potential neuroprotective sildenafil, phosphodiesterase-5 inhibitor, cerebral ischemia model. We explored impact sildenafil on GFAP AQP-4 expression, which markers associated astrocyte activation water homeostasis, respectively. The immunofluorescence analysis revealed that number cells co-expressing markers, increased ischemia-induced group, was significantly reduced sildenafil-treated groups, suggesting mitigating effect activation. Additionally, we conducted diverse behavioral tests, including open-field test, novel object recognition, Barnes maze, Y-maze, passive avoidance assess cognitive function impaired by ischemia. Cognitive improvements were observed following administration (20mg/kg) compared untreated group. Taken together, results presented here suggest sildenafil's as agent alleviating delayed
Язык: Английский
Процитировано
2Kidney Research and Clinical Practice, Год журнала: 2023, Номер 43(6), С. 774 - 784
Опубликована: Авг. 10, 2023
Background: Neurologic complications, such as cognitive and emotional dysfunction, have frequently been observed in chronic kidney disease (CKD) patients. Previous research shows that uremic toxins play a role the pathogenesis of CKD-associated impairment. Since astrocytes contribute to protection survival neurons, astrocyte function brain metabolism may neurodegeneration. Indoxyl sulfate (IS) is most popular toxin. However, how IS-induced injury brings about neurologic complications CKD patients has not elucidated. Methods: The rate extracellular acidification was measured when IS (0.5–3 mM, 4 or 7 days) treatment applied. hexokinase 1 (HK1), pyruvate kinase isozyme M2 (PKM2), dehydrogenase (PDH), phosphofructokinase (PFKP) protein levels were also measured. activation apoptotic pathway investigated using confocal microscope, fluorescence- activated cell sorting, three-dimensional imaging used. Results: In astrocytes, affected glycolysis only dose-dependently but time-dependently. Additionally, HK1, PKM2, PDH, PFKP decreased IS-treated group compared control. results prominent cases with higher doses longer exposure duration. features after observed. Conclusion: Our showed inhibition by leads death via apoptosis. Specifically, longterm higher-dose exposures had more serious effects on astrocytes. suggest related targets could provide novel approach dysfunction
Язык: Английский
Процитировано
5Biomedicines, Год журнала: 2024, Номер 12(9), С. 2077 - 2077
Опубликована: Сен. 12, 2024
Cerebral ischemic stroke is a major cause of death worldwide due to brain cell resulting from ischemia-reperfusion injury. However, effective treatment approaches for patients with are still lacking in clinical practice. This study investigated the potential neuroprotective effects sildenafil, phosphodiesterase-5 inhibitor, gerbil model global ischemia. We sildenafil on expression glial fibrillary acidic protein and aquaporin-4, which markers related astrocyte activation water homeostasis, respectively. Immunofluorescence analysis showed that number cells co-expressing these markers, was elevated ischemia-induced group, significantly reduced sildenafil-treated groups. suggests may have mitigating effect induced by Additionally, we performed various behavioral tests, including open-field test, novel object recognition, Barnes maze, Y-maze, passive avoidance evaluate sildenafil's cognitive function impaired Overall, results suggest serve as agent, potentially alleviating delayed neuronal improving
Язык: Английский
Процитировано
1Experimental Physiology, Год журнала: 2022, Номер 108(2), С. 253 - 267
Опубликована: Ноя. 24, 2022
What is the central question of this study? Are renal changes occurring post-nephrectomy accompanied by cognitive changes, and does early administration zinc supplements such as ZnSO
Язык: Английский
Процитировано
3Brain Sciences, Год журнала: 2024, Номер 14(11), С. 1043 - 1043
Опубликована: Окт. 22, 2024
Uremic toxins resulting from chronic kidney disease (CKD) can cause cognitive and emotional disorders, as well cardiovascular diseases. Indoxyl sulfate (IS) p-cresol are notable uremic found in patients with CKD. However, few studies have investigated whether reducing alleviate disorders associated
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Ноя. 8, 2024
Язык: Английский
Процитировано
0